Solid cosmetic care composition comprising at least one cavity

Abstract

The present invention relates to a solid cosmetic care composition for keratin material, in particular the skin and / or lips, comprising at least one biological / cosmetic active agent, characterized in that said composition comprises at least one cavity such that the composition has a minimum porosity of 20% by volume relative to the total volume of the solid composition, as well as to associated manufacturing processes.

Description

[0001] Solid cosmetic care composition comprising at least one cavity

[0002] The invention relates to a solid cosmetic composition dedicated to the care of a keratin material, in particular the skin and / or the lips.

[0003] We already know solid cosmetic compositions dedicated to the care of keratin material in the form of a stick or powder to be dispersed, generally in water.

[0004] However, such solid care compositions, generally anhydrous, do not give complete satisfaction in terms of deposit homogeneity, comfort, sensoriality, and / or hydration. Indeed, these deposits are generally greasy and / or sticky.

[0005] Furthermore, regarding sticks, their use involves repeated contact between the solid composition and the treated keratin material, which, for obvious reasons, is unhygienic. Furthermore, the degradation of the sticks and / or their breakage and / or disintegration before their total consumption generates waste, and therefore waste.

[0006] Regarding dispersible powders, these are generally water-soluble or water-dispersible powders, to which it is often difficult to add the right amount of water to achieve the desired final liquid composition. Furthermore, their dispersion in an aqueous medium is often perceived by the user as a disappointing experience because of its poor quality. Finally, this gesture makes it difficult to achieve the presence of a fatty (or oily) phase and therefore the presence of lipophilic active ingredients. This explains, at least in part, why this type of composition generally has unsatisfactory sensoriality and effectiveness.

[0007] Solid cosmetic care compositions are already known in the form of single doses. However, these compositions include a lot of packaging, are at least partly disposable and / or have properties that are not entirely satisfactory in terms of grip, ease of application, sensoriality, hydration and / or comfort of application.

[0008] The present invention aims to overcome the aforementioned drawbacks by proposing solid cosmetic care compositions, in particular in single-dose form, guaranteeing good grip by the user, direct and comfortable application, economical in packaging, and which allows the presence of a fatty (or oily) phase and therefore the presence of lipophilic active ingredients.

[0009] Composition

[0010] The invention thus relates to a solid cosmetic composition for caring for a keratin material, in particular for the skin and / or the lips, comprising at least one biological / cosmetic active ingredient, characterized in that said composition comprises at least one cavity such that said composition comprises a porosity greater than or equal to 20%, preferably greater than or equal to 30%, better still greater than or equal to 40%, in particular greater than or equal to 50%, or even greater than or equal to 60%, in particular greater than or equal to 70%, and very particularly greater than or equal to 80%, by volume relative to the total volume of said solid composition.

[0011] Thus, a composition according to the invention may remain endowed with a size and / or a volume similar to current solid care compositions but differ by the presence of at least one cavity such that the porosity of said composition is greater than or equal to 20% by volume relative to the total volume of said composition.

[0012] For the purposes of the present invention, the term "solid" is intended to denote a composition which, at room temperature and atmospheric pressure, is not capable of collapsing under its own weight. Advantageously, it is intended to denote any composition having a compressive strength greater than or equal to 20 g, preferably greater than or equal to 50 g, and better still greater than or equal to 100 g, at room temperature (20-25°C), after penetration by a cylindrical probe of revolution having a diameter of 0.8 cm into the matrix of the composition to a thickness of 1 mm at a speed of 0.5 mm / s and removal of said probe from the matrix of the composition at a speed of 0.5 mm / s; the compressive strength being measured with an analyzer of the "LFRA Texture Analyzer" type marketed by the company STEVENS / MECHTRIC.

[0013] A composition according to the invention is not in the form of a paste. A composition according to the invention is not a powdery composition, and is therefore not in the form of a powder. Finally, a composition according to the invention is also not a porous solid derived from the agglomeration of powders. On the other hand, a composition according to the invention may be an expanded composition, and therefore may be in the form of a foam. According to a particular embodiment, a composition according to the invention is not an expanded composition, and therefore is not in the form of a foam.

[0014] Preferably, a solid composition according to the invention is not coated with a water-soluble coating.

[0015] By "porosity", for the purposes of the present invention, is meant all the voids in a solid material, these voids being able to be filled by fluids, in particular water, when the solid composition is placed in the presence of an aqueous solution, for example water such as tap water.

[0016] For the purposes of the present invention, the term "cavity" is understood to mean an empty space inside a solid body and which communicates directly with the external environment, for example like the cavities illustrated in Figures 1 to 3 and 6. A cavity can therefore be designated indifferently by the terms "orifice", "pore" or "hole". Advantageously, the cavity(ies) is / are through, that is to say that the cavity designates an empty space inside a solid body and which communicates directly with the external environment on either side of the solid body.

[0017] Thus, the volume of the cavity(ies) in a solid composition according to the invention represents at least 20%, in particular at least 30%, preferably at least 40%, in particular at least 50%, or even at least 60%, in particular at least 70%, and very particularly at least 80%, of the total volume of said solid composition.

[0018] Advantageously, a solid composition according to the invention has a density of between 0.2 and 0.8, preferably between 0.3 and 0.7, in particular between 0.4 and 0.6.

[0019] A solid composition according to the invention may have a total volume of between 0.125 cm 3 and 100 cm 3 , preferably between 0.250 cm 3 and 75 cm 3 , especially between 0.5 cm 3 and 50 cm 3 , better between 1 cm 3 and 25 cm 3 , and especially between 2.5 cm 3 and 15 cm 3 .

[0020] A solid composition according to the invention may have a weight of between 0.025 g and 200 g, preferably between 0.25 g and 150 g, in particular between 0.5 g and 100 g, better still between 1 g and 75 g, very particularly between 2.5 g and 50 g, or even between 5 g and 25 g (“g” corresponding to the unit “gram”).

[0021] Advantageously, a solid composition according to the invention may have a weight of between 0.25 g and 200 g, preferably between 0.50 g and 150 g, in particular between 1 g and 100 g, better still between 2.5 g and 75 g, and very particularly between 5 g and 50 g (“g” corresponding to the unit “gram”).

[0022] According to a first preferred embodiment, a solid composition according to the invention comprises a ratio between the volume of the cavities and the total volume of the composition of between 0.05 and 0.9, preferably between 0.1 and 0.8, in particular between 0.2 and 0.9, preferably between 0.2 and 0.8, better still between 0.2 and 0.7, or even between 0.2 and 0.6.

[0023] By "total volume" is meant the volume resulting from the sum of the volume of solid and the volume of the cavities.

[0024] In the context of the present invention, the cavities may be described as macroporosity, i.e. pores whose minimum width, or even diameter, is greater than or equal to 0.5 mm, preferably greater than or equal to 0.75 mm, and in particular greater than or equal to 1 mm, or even between 0.5 mm and 2 cm, very particularly between 1 mm and 2 cm, preferably between 2 mm and 1 cm, in particular between 3 mm and 75 mm, better still between 4 mm and 50 mm, and very particularly between 5 mm and 25 mm. In particular, the pores have a minimum width, or even a diameter, of between 0.5 mm and 5 mm, preferably between 1 mm and 3 mm.

[0025] In this respect, the Applicant indicates that, with equivalent porosity, manufacturing a stable solid composition is:

[0026] - easy in the presence of small cavities, for example those present in solid substrates where the porosity is a consequence of the introduction of a gas during the manufacturing process, like what is described in US 8,349,341, but

[0027] - much more difficult in the presence of macroporosities such as those considered in the present invention.

[0028] The presence of cavities in the contents and / or volumes and / or dimensions considered above makes it possible to access solid compositions that require less raw materials while still having satisfactory gripping properties. A solid composition according to the invention is therefore suitable for a single-dose format, generating no or less loss. This weight saving also has the advantage of allowing less polluting and less expensive transport. A solid composition according to the invention is therefore advantageous both ecologically and economically.

[0029] Furthermore, the inventors observed an unexpected effect in terms of texture and transformative effect when a solid composition according to the invention is placed in the presence of an aqueous phase. Indeed, the inventors observed that a solid composition according to the invention, in contact with an aqueous phase, exhibits faster transformation kinetics between the original solid state to a liquid state, for example of the gel or cream type, compared to a solid composition of the same size and volume but without a cavity. Without wishing to be bound by any theory, the inventors believe that the presence of cavity(ies) within the solid composition makes it possible to facilitate the transition to a viscous liquid composition, for example when the solid composition is mixed with the hands, or allows an increase in the contact surface with the aqueous phase, in particular water, and therefore better hydration of said solid composition.

[0030] Thus, the invention even makes it possible to adjust the speed at which the solid composition will swell and / or melt, by adjusting the surface area developed at constant volume, by adjusting the percentage of porosity, and more particularly by adjusting the shape and / or the number and / or the dimensions of the cavities, or even the number of walls and / or the thickness of the walls of the cavities.

[0031] Advantageously, the size and / or volume of the cavities can be adjusted to store and / or react the right amount of water necessary to achieve a final liquid composition with satisfactory / expected properties, or even optimized and / or homogeneous properties (i.e. between different single doses), for example in terms of viscosity, hydration, ease of spreading, and / or transformative effect.

[0032] Thus, a composition according to the invention even makes it possible to access evanescent compositions, namely those capable of transforming into liquid compositions, in particular in the form of gels or creams, upon contact with an adequate quantity of water.

[0033] Finally, the inventors observed that the porous structure of a solid composition according to the invention makes it possible to obtain deposits on keratin materials which are more homogeneous, even without using application members.

[0034] Preferably, a composition according to the invention is a single-dose composition. This embodiment is particularly advantageous from a hygienic point of view in that it avoids repeated contact between the solid composition and the keratin material. This embodiment also allows easy adaptation for the user of the desired cosmetic effect depending on his state of mind (mood), his clothing style and / or the time of day.

[0035] Thus, the invention also relates to a packaging comprising several solid compositions according to the invention in the form of single doses of different active / cosmetic effect. Thus, the invention relates to a packaging comprising several solid compositions according to the invention, preferably in the form of single doses, said compositions comprising different cosmetic / biological active ingredients and / or contents of different cosmetic / biological active ingredients. This packaging therefore has the advantage of ensuring easy personalization of the treatment for the user depending on their state of mind (mood), their clothing style and / or the time of day.

[0036] Preferably, a composition according to the invention is a topical composition. A composition according to the invention is not an oral composition.

[0037] A solid composition according to the invention may have any shape, for example a spherical, ellipsoidal, tetrahedral, or even polygonal shape, in particular in the shape of a parallelogram, preferably a right-angled parallelogram.

[0038] Preferably, in particular to ensure good grip, a solid composition according to the invention has:

[0039] - a width, or even a diameter, of between 1 cm and 10 cm, preferably between 2 cm and 8 cm, in particular between 3 cm and 6 cm, and better still between 4 cm and 5 cm; and / or

[0040] - a height (or thickness) between 0.5 cm and 5 cm, preferably between 1 cm and 4 cm, and in particular between 2 cm and 3 cm.

[0041] The cavity(ies) of a solid composition according to the invention may be of any shape, for example round, oblong, ovoid, triangular, polygonal, in particular hexagonal, honeycomb, or in the form of a tiling (or cutting), for example of the Voronoi diagram type, preferably in the form of a honeycomb, as illustrated in figures 3 and 6.

[0042] The cavity(ies) of a solid composition according to the invention may also represent letters or the logo of a brand or company, as illustrated in Figure 2.

[0043] A solid composition according to the invention comprises one or more cavities, preferably several cavities, identical or different.

[0044] According to a first variant, a composition according to the invention comprises at least one cavity, in particular a through cavity.

[0045] According to a second preferred variant, a composition according to the invention comprises several cavities, in particular through cavities, as illustrated in figures 3 and 6.

[0046] The cavities are through, advantageously along an axis x - x'.

[0047] According to a particular embodiment, a composition according to the invention may comprise at least two cavities connected to each other. Such an embodiment is advantageous because it makes it possible to promote capillarity phenomena when brought into contact with water, which makes it possible to improve the aforementioned technical effects.

[0048] Advantageously, a solid composition according to the invention comprises several cavities which adopt a honeycomb-shaped structure, as illustrated in Figure 3. This honeycomb shape is particularly advantageous in that it allows the manufacture of a solid composition with a very advantageous “volume of the cavity(ies) / total volume of the composition” ratio, in particular greater than or equal to 0.5, or even greater than or equal to 0.75, without prejudice to the gripping and robustness of said composition to the mechanical stresses likely to be applied to it and / or to storage. In other words, this honeycomb structure offers an excellent compromise between cavity volume and mechanical strength.

[0049] Advantageously, the cavity(ies) of a solid composition according to the invention comprises / comprise walls having a thickness of between 10 μm and 1,500 μm, preferably between 20 μm and 1,000 μm, in particular between 30 μm and 750 μm, very particularly between 50 μm and 500 μm, or even between 100 μm and 400 μm. In particular, the cavity(ies) of a solid composition according to the invention comprises / comprise walls having a thickness of between 250 μm and 500 μm.

[0050] Advantageously, a solid composition according to the invention comprises several cavities which adopt a honeycomb-shaped structure comprising walls having a thickness of between 10 pm and 600 pm, preferably between 20 pm and 500 pm, in particular between 30 pm and 400 pm, very particularly between 50 pm and 300 pm, or even between 100 pm and 200 pm.

[0051] According to a particular embodiment, a solid composition according to the invention, in particular when it adopts a honeycomb-type configuration as described above, may comprise a plurality of sections, in particular polygonal sections, each of the sections defining a fracturable perimeter allowing the separation of at least one section from the rest of the solid composition. Thus, according to this embodiment, each section of the solid composition corresponds to a single dose.

[0052] According to a particular embodiment, a composition according to the invention may further comprise additional patterns distinct from the cavities, said patterns being able for example to be produced by embossing.

[0053] According to a first variant, a composition according to the invention is anhydrous. For the purposes of the present invention, the term "anhydrous" is intended to denote a composition which, before any contact with water, comprises a water content of less than 5% by weight, preferably less than 1% by weight and in particular less than 0.5% by weight, relative to the total weight of said composition.

[0054] According to a second variant, a composition according to the invention comprises a continuous fatty phase and a dispersed aqueous phase. Thus, a composition according to the invention is in the form of an oily (or fatty) phase which further comprises at least one dispersed aqueous phase, for example in encapsulated form such as for example in the form of matrix spheres (or pearls or beads) or of core / shell type (or capsules), for example in the form of capsules as described in WO2010 / 063937.

[0055] Thus, a solid composition according to the invention may further comprise at least one aqueous phase dispersed in the solid composition, preferably in encapsulated form.

[0056] According to one embodiment, the mass percentage of water in the dispersed aqueous phase may then be between 0.5% and 50%, preferably between 1% and 40%, in particular between 2.5% and 30%, and better still between 5% and 20%, by weight relative to the total mass of the composition.

[0057] The solid nature of a composition according to the invention may be based on a phase consisting mainly, or even entirely, of a fatty phase comprising at least one lipophilic gelling agent (also referred to below as “solid fatty phase”).

[0058] Preferably, the solid nature of a composition according to the invention is based on the presence of a fatty phase comprising at least one lipophilic gelling agent.

[0059] Fat phase

[0060] The dispersed fatty phase of a composition according to the invention has a melting point of between 50°C and 100°C, preferably between 60°C and 90°C.

[0061] The melting point of a fatty phase can be measured using a differential scanning calorimeter (DSC), for example the calorimeter sold under the name "DSC Q2000" by TA Instruments. The sample preparation and measurement protocols are as follows: a 5 mg sample of the sample to be tested, previously heated to 80°C and taken under magnetic stirring using a heated spatula, is placed in a hermetic aluminum dish, or crucible. Two tests are carried out to ensure the reproducibility of the results. The measurements are carried out on the calorimeter mentioned above. The furnace is subjected to a nitrogen flush. Cooling is provided by the RCS 90 heat exchanger.The sample is then subjected to the following protocol by first being heated to 20°C, then subjected to a first temperature rise from 20°C to 130°C, at a heating rate of 5°C / minute, then cooled from 130°C to -80°C at a cooling rate of 5°C / minute and finally subjected to a second temperature rise from -80°C to 130°C at a heating rate of 5°C / minute. During the second temperature rise, the variation in the difference in power absorbed by the empty crucible and by the crucible containing the sample as a function of temperature is measured. The melting point of the compound is the temperature value corresponding to the top of the peak of the curve representing the variation in the difference in power absorbed as a function of temperature. The end of melting temperature corresponds to the temperature at which 95% of the sample has melted.

[0062] Lipophilic gelling agent

[0063] A composition according to the invention advantageously comprises at least one lipophilic gelling agent.

[0064] The lipophilic gelling agent according to the invention may be chosen from organic or mineral, polymeric or molecular lipophilic gelling agents; fatty substances which are solid at ambient temperature and pressure; and mixtures thereof.

[0065] The solid fatty substances at room temperature and pressure are preferably chosen from at least one wax, at least one pasty fatty substance, at least one butter, and their mixtures.

[0066] Advantageously, a lipophilic gelling agent is a heat-sensitive gelling agent, i.e. one which reacts to heat, and in particular is a gelling agent which is solid at room temperature and liquid at a temperature above 50°C, preferably above 60°C, and better still above 70°C. Preferably, a heat-sensitive lipophilic gelling agent according to the invention has a melting point of between 50°C and 130°C, and preferably between 60°C and 120°C.

[0067] As lipophilic gelling agent(s), mention may be made, for example, of those described in WO2021 / 234135.

[0068] According to a particularly preferred embodiment, the lipophilic gelling agent is chosen from Castor Oil / IPDI Copolymer (and) Caprylic / Capric Triglyceride, in particular marketed under the name Estogel M by PolymerExpert, Hydrogenated Castor Oil / Sebacic Acid Copolymer and its derivatives, in particular marketed respectively under the names Estogel Green (or Estogel G) and Estogel Green 40 by PolymerExpert, Caprylic / Capric Triglyceride (and) Polyurethane-79, in particular marketed under the name OILKEMIA™ 5S polymer by the company Lubrizol, Trihydroxystearin, in particular marketed under the name THIXCIN® R by the company Elementis Specialties, and their mixtures, and better still Castor Oil / IPDI Copolymer (and) Caprylic / Capric Triglyceride.

[0069] In particular, a composition according to the invention may comprise from 10% to 90%, preferably from 20% to 80%, in particular from 30% to 70%, and better still from 40% to 60%, by weight of lipophilic gelling agent(s) relative to the total weight of the composition.

[0070] Oils

[0071] A composition according to the invention may comprise at least one oil. The term “oil” means a fatty substance that is liquid at room temperature and atmospheric pressure.

[0072] Examples of oils according to the invention include:

[0073] - hydrocarbon oils of vegetable origin, as described below;

[0074] - hydrocarbon oils of animal origin, such as perhydrosqualene and squalane;

[0075] - synthetic esters and ethers, in particular of fatty acids, such as oils of formulas R COOR2 and R1OR2 in which R1 represents the residue of a C8 to C29 fatty acid, and R2 represents a branched or unbranched C3 to C30 hydrocarbon chain, such as for example Purcellin oil, isononyl isononanoate, isodecyl neopentanoate, isostearyl neopentanoate, isopropyl myristate, octyldodecyl myristate, 2-ethylhexyl palmitate, 2-octyldodecyl stearate, 2-octyldodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octylhydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate, fatty alcohol heptanoates, octanoates, decanoates; polyol esters, such as propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate;and pentaerythritol esters such as pentaerythrityl tetrabehenate (DUB PTB) or pentaerythrityl tetraisostearate (Prisorine 3631);

[0076] - linear or branched hydrocarbons, of mineral or synthetic origin, such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam oil;

[0077] - silicone oils, such as, for example, volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane and cyclopentasiloxane; polydimethylsiloxanes (or dimethicones) comprising alkyl, alkoxy or phenyl groups, pendant or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyldimethicones, diphenylmethyldiphenyl trisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes;

[0078] - fatty alcohols with 8 to 26 carbon atoms, such as cetyl alcohol, stearyl alcohol and their mixture (cetylstearyl alcohol), or octyldodecanol;

[0079] - partially hydrocarbon and / or silicone fluorinated oils such as those described in document JP-A-2-295912;

[0080] - and their mixtures.

[0081] Examples of oils that can be mentioned are those described in WO2021 / 234135.

[0082] A composition according to the invention preferably comprises at least one vegetable oil, such as for example copra oil, coconut oil, olive oil, sweet almond oil, castor oil, babassu oil, and mixtures thereof.

[0083] In particular, a composition according to the invention may comprise from 10% to 90%, preferably from 20% to 80%, in particular from 30% to 70%, and better still from 40% to 60%, by weight of oil(s) relative to the total weight of the composition.

[0084] A composition according to the invention may comprise at least one lipophilic gelling agent, preferably heat-sensitive, at least one oil and their mixtures.

[0085] Biological / cosmetic active ingredient

[0086] A solid composition according to the invention, in particular the fatty phase and / or the dispersed aqueous phase (when present), comprises at least one biological / cosmetic active ingredient.

[0087] As biological / cosmetic active ingredient according to the invention, mention may be made of moisturizing agents, vitamins, healing agents, anti-wrinkle or anti-aging agents, depigmenting agents, desquamating agents, antioxidant agents, active ingredients stimulating the synthesis of dermal and / or epidermal macromoleculars, dermo-contracting agents, antiperspirant agents, soothing agents and / or anti-aging agents, and mixtures thereof.

[0088] Anti-wrinkle or anti-aging agents

[0089] As representatives of anti-wrinkle or anti-aging agents that can be used in the present invention, mention may more particularly be made of adenosine, retinol and its derivatives, ascorbic acid and its derivatives, such as magnesium ascorbyl phosphate and ascorbyl glucoside; tocopherol and its derivatives, such as tocopheryl acetate; nicotinic acid and its precursors, such as nicotinamide; ubiquinone; glutathione and its precursors, such as L-2-oxothiazolidine-4-carboxylic acid; C-glycoside compounds and their derivatives, as described in particular below; plant extracts and in particular extracts of fennel and olive leaf, as well as plant proteins and their hydrolysates, such as hydrolysates of rice or soy proteins; or extracts of Vigna aconitifolia seeds such as those marketed by the company Cognis under the references Vitoptine LS9529 and Vit-A-Like LS9737;extracts of algae and in particular of laminaria; bacterial extracts; sapogenins, such as diosgenin and extracts of Dioscorea, in particular of Wild Yam, containing them; α-hydroxy acids; [3-hydroxy acids, such as salicylic acid and n-octanoyl-5-salicylic acid; oligopeptides and pseudodipeptides and their acylated derivatives, in particular {2-[acetyl-(3-trifluoromethyl-phenyl)-amino]-3-methyl-butyrylamino} acetic acid and lipopeptides marketed by the company SEDERMA under the trade names Biopeptide CL, Matrixyl 500 and Matrixyl 3000; lycopene; manganese and magnesium salts, in particular gluconates; rye seed extract under the trade name Coheliss from Silab; an extract of centella asiatica leaves; oily or aqueous extracts of vanilla planifolia fruit, vanilla planifolia flower extract; and mixtures thereof.;

[0090] Humectants or moisturizers

[0091] Humectant or moisturizing agents include glycerin; diglycerin; glycols, such as sorbitol; betaines; urea and its derivatives, including Hydrovance® marketed by National Starch; monosaccharides such as mannose, AHAs, BHAs, beta-glucan and in particular sodium carboxymethyl beta-glucan from Mibelle-AG-Biochemistry; polyoxybutylene, polyoxyethylene, or polyoxypropylene glycerol such as WILBRIDE S-753L® from NOF corporation; rosehip oil marketed by Nestlé; marine collagen and chondroitin sulfate spheres (Ateocollagen) marketed by Engelhard Lyon under the name marine filling spheres; niacinamide; glyceryl polymethacrylate from Sederma sold under the trade name Lubragel®MS; trimethylglycine sold under the trade name Aminocoat® by the company Ashahi Kasei Chemicals;mother-of-pearl extracts containing conchiolin sold in particular by the company Maruzen (Japan) under the trade name Pearl Extract®; plant extracts such as an extract of Castanea sativa or aqueous or oily extracts of Camellia japonica flower and in particular of the alba plena variety; hydrolyzed hazelnut proteins; polysaccharides of Polyanthes tuberosa; Argania spinosa kernel oil; homo- and co-polymers of 2-methacryloyloxyethylphosphorylcholine acid, such as Lipidure HM and Lipidure PBM from NOF; saccharides such as glucose, fructose, mannose or trehalose; glycosaminoglycans and their derivatives such as hyaluronic acid, sodium hyaluronate and acetylated hyaluronic acid, in particular hyaluronic acid spheres such as those marketed by the company Engelhard Lyon; panthenol; allantoin; aloe vera; free amino acids and their derivatives; glucosamine; citric acid;ceramides; and mixtures thereof.;

[0092] Peeling agents

[0093] As desquamating agents, mention may be made of beta-hydroxy acids, in particular salicylic acid and its derivatives other than 5-n-octanoyl salicylic acid; urea; glycolic, citric, lactic, tartaric, malic or mandelic acids; 4-(2-hydroxyethyl)piperazine-1-propanesulfonic acid (HEPES); Saphora japonica extract; honey; N-acetyl glucosamine; sodium methyl glycine diacetate, alpha-hydroxy acids (AHAs), beta-hydroxy acids (BHAs), and mixtures thereof.

[0094] Antioxidant agents

[0095] As antioxidant agents, mention may be made more particularly of tocopherol and its esters, in particular tocopherol acetate; EDTA, ascorbic acid and its derivatives, in particular ascorbyl magnesium phosphate and ascorbyl glucoside; chelating agents, such as BHT, BHA, N, N' bis(3,4,5-trimethoxybenzyl) ethylenediamine and its salts, and mixtures thereof.

[0096] Dermo-contracting or dermorelaxing agents

[0097] As dermo-decontracting or dermorelaxing agents, we can particularly mention manganese gluconate, wild yam, sea fennel, glycine, alverine, and their mixtures.

[0098] Active ingredients stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation

[0099] As active ingredients stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation, mention may be made of peptides extracted from plants, such as soy hydrolyzate marketed by BASF Beauty Care Solutions under the trade name Phytokine®, malt extract such as marketed under the name Collalift® by BASF BCS; rice peptides such as Nutripeptide® from SILAB, or a rice peptide extract such as Colhibin® from Pentapharm DSM, methylsilanol mannuronate such as Algisium C® marketed by Exsymol; a vaccinium myrtillus extract such as those described in application FR-A-2 814 950; lupin extract marketed by SILAB under the trade name Structurine®, verbena hydrosol, and mixtures thereof.

[0100] Soothing agents

[0101] As a soothing agent, we can cite dipotassium glycyrrhizate or Acetyl Dipeptide-1 Cetyl Ester under the name Calmosensine from SEDERMA.

[0102] Depigmenting agents

[0103] Depigmenting agents include ceramides, vitamin C and its derivatives, including vitamin C, CP and 3-O ethyl vitamin C, alpha and beta arbutin, ferulic acid, kojic acid, resorcinol and its derivatives, including 4-butyl resorcinol, tranexamic acid and its derivatives, D calcium panthetine sulfonate, lipoic acid, ellagic acid, vitamin B3, phenylethyl resorcinol such as Symwhite 377® from Symrise, a kiwi fruit water (Actinidia chinensis) marketed by Gattefosse, a Paeonia suffructicosa root extract such as that marketed by Ichimaru Pharcos under the name Botanpi Liquid B®, a licorice extract (glycyrrhiza glabra), a brown sugar extract (Saccharum officinarum), such as the molasses extract marketed by Taiyo Kagaku under the name Molasses Liquid, a mixture of undecylenic acid and undecylenoyl phenylalanine, such as Sepiwhite MSH® from Seppic.

[0104] Mention may also be made of vitamins B3, B5, B6, B8, C, E, or PP, niacin, carotenoids, polyphenols and minerals such as zinc, calcium, magnesium, etc. In particular, use may be made of an antioxidant complex comprising vitamins C and E, and at least one carotenoid, in particular a carotenoid chosen from p-carotene, lycopene, astaxanthin, zeaxanthin and lutein, flavonoids such as catechins, hesperidin, proanthocyanidins and anthocyanins.

[0105] It may also be at least one prebiotic or a mixture of prebiotics. More particularly, these prebiotics may be chosen from oligosaccharides, produced from glucose, galactose, xylose, maltose, sucrose, lactose, starch, xylan, hemicellulose, inulin, acacia-type gums for example, or a mixture thereof. More particularly, the oligosaccharide comprises at least one fructo-oligosaccharide. More particularly, this prebiotic may comprise a mixture of fructo-oligosaccharide and inulin.

[0106] In particular, a solid composition according to the invention comprises between 0.0001% and 60%, preferably between 0.001% and 50%, in particular between 0.01% and 40%, in particular better between 0.1% and 35%, and preferably between 1% and 25%, by weight of biological / cosmetic active ingredient(s) relative to the total weight of said composition.

[0107] Additional compounds

[0108] A composition according to the invention, in particular the fatty phase, or even the dispersed aqueous phase when present, may further comprise at least one additional compound different from the lipophilic gelling agents, oils and biological / cosmetic active ingredients mentioned above.

[0109] A composition according to the invention may also comprise powders; glitter; coloring agents, in particular chosen from water-soluble or non-water-soluble, fat-soluble or non-fat-soluble, organic or inorganic coloring agents, materials with an optical effect, liquid crystals, and mixtures thereof; particulate agents insoluble in the fatty phase; perfuming agents; preservatives; humectants; fillers with a blurring effect; UV filters; effervescent agents; disintegrating agents (e.g. croscarmellose, carboxymethylcellulose, etc.); diluents; disintegration promoters; stabilizers; chelators; emollients; modifying agents chosen from texturizing agents (or gelling agents) and in particular hydrophilic gelling agents, pH, osmotic force and / or refractive index modifiers, etc., or any usual cosmetic additive; and mixtures thereof.For the purposes of the invention, the term "particulate agents insoluble in the fatty phase" means the group consisting of pigments, ceramics, polymers, in particular acrylic polymers, and their mixtures.

[0110] As hydrophilic gelling agents, we can for example cite those described in FR3041251.

[0111] A composition according to the invention may further comprise at least one solvent capable of evaporating in whole or in part during the manufacturing process, as described below. As a solvent, mention may for example be made of an apolar or slightly polar organic solvent, for example cyclohexane, THF (tetrahydrofuran), and mixtures thereof.

[0112] Of course, the skilled person will take care to choose the raw materials, ingredient(s), active ingredient(s) and / or additional compound(s) described above and / or their quantity in such a way that the advantageous properties of the composition according to the invention are not or are not substantially altered by the envisaged addition. Also, the skilled person will take care to choose the nature and / or the quantity of raw materials, ingredient(s), active ingredient(s) and / or additional compound(s) described above according to the aqueous or fatty nature of the phase considered and / or with regard to the manufacturing process of the composition. These adjustments fall within the general knowledge of the skilled person.

[0113] The solid nature of a composition according to the invention advantageously makes it possible to do without conventional packaging. Indeed, the packaging of a solid composition according to the invention can, for example, be limited to a simple package such as a sheet of paper.

[0114] Advantageously, a solid composition according to the invention does not consist of a network of fibers.

[0115] Preferably, a composition according to the invention does not comprise a surfactant.

[0116] Preferably, a solid composition according to the invention does not comprise polyvinyl alcohol (PVA or PVOH), polyacrylate, copolymer of acrylic acid and methacrylic acid, polyvinylidene fluoride (PVDF), polymethyl methacrylate (PMMA), polyvinylpyrrolidone, polyalkylene oxide, polyacrylonitrile (PES or PAN), polyethylene terephthalate methacrylate, polyethylene, polypropylene, nylon, hyaluronic acid, starch and its derivatives, pullulan, gelatin, cellulose (e.g. rayon), hydroxypropylmethylcellulose, methylcellulose, carboxymethylcellulose, cotton, and a mixture thereof. A composition according to the invention does not comprise (or is not based on) a water-soluble solid support, for example of the hydrogel type, in particular based on starch, where appropriate destructured, and / or poloxamer 407.

[0117] Manufacturing process

[0118] A composition according to the invention is obtained by any process known to those skilled in the art suitable for the manufacture of a solid composition, subject to the necessary adaptations to ensure the formation of cavities and therefore satisfy the required porosity criterion.

[0119] Preferably, the method for manufacturing a solid composition according to the invention does not include a step of aeration / injection of a gas, for example air, where appropriate followed by a step of forming and then drying.

[0120] Process No. 1

[0121] According to a first variant, a method for manufacturing a composition according to the invention comprises at least the steps consisting of:

[0122] (i) have a composition in liquid or semi-liquid form;

[0123] (ii) pouring the composition into a mold and drying until a solid composition is obtained,

[0124] (iii) cutting the solid composition into the desired shape, and

[0125] (iv) forming cavities to obtain a solid composition according to the invention.

[0126] Step (i) is advantageously carried out hot.

[0127] Advantageously, steps (iii) and (iv) are simultaneous.

[0128] Advantageously, steps (ii), (iii) and (iv) are simultaneous, in which case the mold has a shape adapted to ensure the formation of the cavity(ies).

[0129] Step (iv) is advantageously carried out using a cookie cutter.

[0130] Process No. 1 is advantageous in that the scraps obtained at the end of step (iv) can be recovered during subsequent production. In fact, these scraps can be heated again and reintroduced into a subsequent process No. 1 at step (i) and / or (ii).

[0131] Process No. 2

[0132] According to a second variant, a method of manufacturing a composition according to the invention is an extrusion method.

[0133] Such a manufacturing method according to the invention comprises at least the steps consisting of:

[0134] (a) have a composition in liquid or semi-liquid form;

[0135] (b) passing the composition of step (a) through an extrusion device provided with a die (or extrusion grid) of a shape suitable for forming a solid bar, and

[0136] (c) cutting the bar obtained in step (b) to obtain a solid composition according to the invention.

[0137] For obvious reasons, step (b) is carried out at a temperature suitable for providing a composition with sufficient viscosity and capable of retaining the shape assigned by the die.

[0138] For obvious reasons, the shape of the die of the extrusion device is also adapted to ensure the formation of the cavity(ies).

[0139] Advantageously, step (b) is carried out at a temperature lower than room temperature, and for example at a temperature lower than or equal to 15°C, or even lower than or equal to 10°C.

[0140] At step (b), the extrusion device comprises a die having a shape adapted to form the desired cavity(ies) and level of porosity in the solid bar.

[0141] By way of illustration, an extrusion method according to the invention comprises a die such as that illustrated in Figure 4.

[0142] Step (c) can be done using a knife or a wire, such as a butter cutter.

[0143] Preferably, steps (b) and (c) are simultaneous.

[0144] Preferably, the method for manufacturing a composition according to the invention is extrusion method no. 2 described above.

[0145] According to a particular embodiment, applicable to processes No. 1 and No. 2 described previously, step (i) / (a) consists of having a fluid composition which may comprise at least one solvent capable of evaporating in whole or in part during step (ii) / (b), or even further during step (iii) and / or (iv) / (c).

[0146] As a solvent, we can for example cite a non-polar or slightly polar organic solvent, for example cyclohexane, THF (tetrahydrofuran), and their mixture.

[0147] In processes No. 1 and No. 2 above, when the composition comprises at least one fatty phase comprising at least one lipophilic gelling agent, step (i) / (a) may require heating said composition to a temperature above the highest melting point of the lipophilic gelling agents present in said composition.

[0148] According to a particular embodiment, extrusion process No. 2 can be carried out using a 3D printing technique.

[0149] Use

[0150] A composition according to the invention is dedicated to the care of a keratin material, in particular the skin and / or the lips.

[0151] In particular, depending on whether the solid composition according to the invention is intended for direct application to a keratin material or requires prior mixing with an aqueous medium, a composition according to the invention may for example be a cream, a lotion, a serum and a gel for the skin (hands, face, feet, etc.), a hair care product (hair dyes and bleaches), a hair care product (lotions, creams, oils), a styling product (lotions, hairsprays, brilliantines), a shaving product (soaps, mousses, lotions, etc.), a product intended to be applied to the lips, a product for whitening the skin, an anti-wrinkle product. In particular, the cosmetic compositions of the invention may be an anti-aging serum, a youth serum or a moisturizing serum.

[0152] Advantageously, a solid composition according to the invention is not in the form of a mask.

[0153] A solid composition according to the invention is not a composition dedicated to the makeup of a keratin material only. On the other hand, a solid composition according to the invention may be a BB Cream or a CC cream and therefore also comprise at least one pigment.

[0154] According to a first embodiment, in particular when a composition according to the invention is of the single-dose type, a solid composition according to the invention is intended for direct contact with a keratin material.

[0155] According to a second embodiment, a solid composition according to the invention is intended to be brought into contact with an aqueous phase, in particular water before, simultaneously and / or after its application to the keratin material to be treated. When a composition according to the invention is not of the single-dose type, contact with water is carried out during the first use only, and assumes packaging of the “solid composition / water” mixture in a suitable receptacle. For obvious reasons, this requires a solid composition of suitable formula and a sufficient quantity of water to ensure the transition from a solid composition to a liquid composition, for example in the form of a gel. Also, this requires the presence in the solid composition of at least one preservative to guarantee good preservation over time of the liquid composition thus formed.

[0156] Finally, the present invention also relates to a non-therapeutic cosmetic treatment process for the care of a keratin material, in particular the skin and / or the lips, comprising at least one step of applying to said keratin material at least one composition as defined above.

[0157] According to a particular embodiment, the present invention relates to a product comprising, or deriving from the contact between, at least one first solid composition as described above and at least one second liquid composition.

[0158] First solid composition

[0159] For the purposes of the present invention, the first composition may be referred to indifferently as “first solid composition” or “solid composition”, and corresponds to a solid composition as described above.

[0160] Second liquid composition

[0161] For the purposes of the present invention, the second composition may be referred to indifferently as “second liquid composition” or “liquid composition”.

[0162] According to a first variant, the second composition is aqueous.

[0163] According to a second variant, the second composition is anhydrous.

[0164] According to a third variant, the second composition is an emulsion. An emulsion may be a direct (i.e. oil-in-water), inverse (i.e. water-in-oil) or multiple, in particular double (i.e. water-in-oil-in-water, oil-in-water-in-oil or oil-in-oil-in-water) emulsion.

[0165] According to a particular embodiment, the second composition is an emulsion, preferably direct, stable and highly concentrated in dispersed phase, and in particular is an emulsion of the HIPE (i.e. “High Internal Phase Emulsion”) or Apollonian type.

[0166] A second composition according to the invention is not in a solid form at room temperature and at ambient pressure, that is to say it is capable of flowing under its own weight. A second composition according to the invention is in a liquid form, preferably in the form of a gel.

[0167] The viscosity of a second composition or at least of its continuous phase when in the form of an emulsion, can vary significantly, which makes it possible to obtain varied textures. The viscosity is measured at room temperature and at ambient pressure according to the method described in WO2017 / 046305.

[0168] For obvious reasons, the viscosity of the second composition is adjusted to allow easy sampling / administration of the product according to the invention.

[0169] According to one embodiment, the second composition advantageously has a viscosity of from 5,000 mPa.s to 500,000 mPa.s, preferably from 10,000 mPa.s to 300,000 mPa.s, better still from 25,000 mPa.s to 100,000 mPa.s, and more particularly from 50,000 mPa.s to 75,000 mPa.s, as measured at 25°C according to the method described above.

[0170] Preferably, the second composition can reduce the solidity of the first composition. In particular, the second composition can advantageously comprise at least one raw material capable of reducing the solidity of the first composition. This embodiment is advantageous in that it makes it possible to change the solid texture of the first composition towards a softer texture. We can thus speak of a “transformative effect”.

[0171] A product according to the invention may advantageously comprise a “first composition(s) / second composition(s)” weight ratio of between 0.01 and 10, preferably between 0.1 and 5, and better still between 0.5 and 1.

[0172] According to a particular embodiment, the first composition may comprise high contents of biological / cosmetic active ingredient(s) as described below. Thus, the first composition may be described as a “booster”.

[0173] In view of the above, a product according to the invention is an extemporaneous product, that is to say that it is the user, during the first use of the product, who will bring the first composition and the second composition into contact.

[0174] Thus, the invention also relates to a kit comprising:

[0175] - at least one first solid composition as described previously;

[0176] - at least one second liquid composition as described above; and

[0177] - optionally, at least one container. A container may be referred to indifferently as “receptacle”, “packaging” or “primary packaging”.

[0178] The invention also relates to the use of the kit described above, to obtain a product according to the invention.

[0179] Preferably, a kit according to the invention may further comprise at least one application / administration means.

[0180] In the case where the product is intended for cosmetic use, a kit according to the invention may further comprise at least one means of application to a keratin material, for example chosen from the group formed by spatulas, brushes, brushes, feathers or sponges.

[0181] According to a particular variant, the kit may comprise several first compositions, identical or different, and / or several second compositions, identical or different, and / or at least one means of application.

[0182] Thus, the invention also relates to a kit comprising several first compositions in the form of single doses comprising different cosmetic / biological active ingredients and / or contents of cosmetic / biological active ingredient(s).

[0183] Thus, such a kit according to the invention advantageously allows easy adaptation for the user of the desired effect.

[0184] In the case of a cosmetic product, this particular embodiment allows the user to decide on the desired cosmetic effect, in particular depending on their state of mind (mood), their clothing style and / or the time of day.

[0185] DESCRIPTION OF FIGURES

[0186] Figure 1 represents a composition according to the invention of parallelepiped shape provided with a cylindrical cavity. A corresponds to the side view and B corresponds to the top view.

[0187] Figure 2 represents a composition according to the invention of ovoid shape provided with cavities (top view), representing the word “SOAP”.

[0188] Figure 3 represents a composition according to the invention provided with honeycomb cavities (top view).

[0189] Figure 4 represents a die used for the process of the invention.

[0190] Figure 5 represents a comparative chain.

[0191] Figure 6 represents other examples of solid compositions according to the invention.

[0192] EXAMPLES

[0193] Example 1 - Comparative study

[0194] Step 1 - manufacturing:

[0195] Sufficient Quantity For

[0196] Introduce the ingredients of phase A into a container and heat the mixture while stirring to 100°C until homogenized;

[0197] Cool to 80°C and add the ingredients of phase B while stirring until homogenized;

[0198] Step 2 - Extrusion:

[0199] - The mixture obtained in step 1 is injected into an extruder provided, in a first case, with a die according to the invention as illustrated in figure 4 and in a second case, with a comparative die as illustrated in figure 5;

[0200] - At the outlet of the die, the extruded loaves are cut to obtain the weights and volumes described in table 1 below.

[0201] - Single-dose solid care compositions are obtained, respectively, in the form of a solid composition according to the invention with a honeycomb structure (test 1, for example like those described in figure 6) and a comparative solid composition with a general shape identical to test 1 but without a cavity (soaps 2 and 3).

[0202] Step 3 - application: Step 3 is carried out on a panel of 18 women between 22 and 47 years old (hereinafter the

[0203] “candidates”), 3 groups then being formed, each group being made up of 6 women (groups A, B and C).

[0204] For each group, the candidates apply the tested composition to their facial skin. Each of groups A, B and C will use tests 1, 2 and 3, but each time in different orders.

[0205] In this stage 3, the candidates evaluate the performances of tests 1, 2 and 3 in terms of (i) gripping capacity, (ii) homogeneity of the applied deposit, (iii) comfort on application and (iii) state of the composition after use.

[0206] Rating criteria: The average results obtained with the three groups A, B and C are presented in the following table, it being understood that the trends observed are identical between the three groups.

[0207] With comparative tests 2 and 3, we observe that when the size is too small, the grip is poor and it is difficult to handle and when it is too large, it is not possible to consume it completely during single-dose use which generates a lot of losses.

[0208] Furthermore, tests 2 and 3 show average properties in terms of deposit homogeneity and application comfort.

[0209] Test 1 according to the invention makes it possible to combine the advantages of comparative tests 2 and 3 without their disadvantages.

[0210] A composition according to the invention, thanks to the presence of cavities in the contents considered, makes it possible to access solid care compositions combining a capacity to generate a homogeneous deposit with less material while generating less loss and presenting satisfactory homogeneity and comfort of application, and this without prejudice to the gripping properties.

[0211] A solid composition according to the invention therefore requires less raw materials and is therefore advantageous both ecologically and economically. Example 2 - Product / Kit with Vitamin C Booster

[0212] We have a first solid composition according to the table below, in the same format as that described in test 1 above.

[0213] A second liquid composition is available according to the table below. Protocol for preparing the second composition:

[0214] First, the xanthan and hyaluronic acid were dispersed in the glycols (glycerol and propanediol) by stirring using a paddle stirrer. Then, the oligogeline was added and stirring continued for about 30 minutes. Finally, the water and ethanol were added and everything was mixed using a paddle stirrer for about 2 hours. The second composition thus obtained is transparent. Use:

[0215] From a kit according to the invention, the first composition is mixed extemporaneously with approximately 500 mg of the second composition, whereby a product according to the invention is obtained.

[0216] It is observed that the second composition allows to reduce the solidity of the first composition. In particular, the second composition allows to evolve the solid texture of the first composition towards a soft texture, easily applicable and very fresh and comfortable.

Claims

DEMANDS 1. Solid cosmetic composition for the care of a keratinous material, in particular of the skin and / or lips, comprising at least one biological / cosmetic active ingredient, characterized in that said composition comprises at least one cavity such that said composition comprises a porosity greater than or equal to 20% by volume relative to the total volume of said solid composition.

2. Solid composition according to claim 1, wherein the porosity is greater than or equal to 30%, preferably greater than or equal to 40%, in particular greater than or equal to 50%, or even greater than or equal to 60%, in particular greater than or equal to 70%, and most particularly greater than or equal to 80%, by volume relative to the total volume of said solid composition.

3. Solid composition according to claim 1 or 2, in which the cavity(ies) is / are through-hole(s).

4. Solid composition according to any one of the preceding claims, said composition comprising one or more cavities, preferably several cavities, identical or different.

5. Solid composition according to any one of the preceding claims, wherein the cavity(ies) are round, oblong, ovoid, triangular, polygonal, honeycomb, or in the form of a tiling (or cutting), for example of the Voronoi diagram type, preferably in the form of a honeycomb.

6. Solid composition according to any one of the preceding claims, wherein the ratio between the volume of the cavity(ies) and the total volume of the composition is between 0.2 and 0.9, preferably between 0.2 and 0.8, better between 0.2 and 0.7, or even between 0.2 and 0.

6.

7. Solid composition according to any one of the preceding claims, wherein the biological / cosmetic active ingredient is selected from moisturizing agents, vitamins, anti-wrinkle or anti-aging agents, healing agents, depigmenting agents, desquamating agents, antioxidant agents, actives stimulating the synthesis of dermal and / or epidermal macromolecular molecules, dermo-contracting agents, anti-perspirant agents, soothing agents and / or anti-aging agents, and their mixtures.

8. Solid composition according to any one of the preceding claims, wherein said composition comprises between 0.0001% and 60%, preferably between 0.001% and 50%, in particular between 0.01% and 40%, in particular better between 0.1% and 35%, and preferably between 1% and 25%, by weight of biological / cosmetic active ingredient(s) relative to the total weight of said composition.

9. Solid composition according to any one of the preceding claims, wherein said composition comprises at least one lipophilic gelling agent, preferably thermosensitive, at least one oil, and a mixture thereof.

10. Solid composition according to any one of the preceding claims, wherein said composition further comprises at least one aqueous phase dispersed in the solid composition, preferably in encapsulated form.

11. Solid composition according to any one of the preceding claims, wherein said composition is a single-dose composition.

12. Kit includes: - at least one first solid composition according to any one of claims 1 to 11; - at least one second liquid composition; and - optionally, at least one container.

13. Packaging comprising several solid compositions according to any one of claims 1 to 11, preferably in the form of single doses, said compositions comprising different cosmetic / biological active ingredients and / or contents of different cosmetic / biological active ingredient(s).

14. A method for manufacturing a solid cosmetic composition according to any one of claims 1 to 11, comprising at least the steps of: (i) have a composition in liquid or semi-liquid form; (ii) pour the composition into a mold and dry until a solid composition is obtained, (iii) cut the solid composition into the desired shape, and (iv) formation of cavities to obtain a solid composition according to any one of claims 1 to 11.

15. A method for manufacturing a solid cosmetic composition according to any one of claims 1 to 11, comprising at least the steps of: (a) have a composition in liquid or semi-liquid form; (b) pass the composition of step (a) through an extrusion device equipped with a die of suitable shape to form a solid bar, and (c) cutting the bar obtained in step (b) to obtain a solid composition according to any one of claims 1 to 11.

16. Non-therapeutic cosmetic treatment process for the care of keratinous material, in particular of the skin and / or lips, comprising at least one step of applying to said keratinous material at least one composition according to any one of claims 1 to 11.

Images